HSBC analyst Damayanti Kerai downgraded Alembic Pharmaceuticals (ALPM:IN) from Hold to Reduce with a price target of INR1,010.00.The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE